文献速递肿瘤 PET/CT

Lugano标准与RECIL及PERCIST作为弥漫性大B细胞淋巴瘤预后因素的比较

Comparison of Lugano Criteria Versus RECIL and PERCIST as Prognostic Factors in Diffuse Large B-Cell Lymphoma.
PubMed 文献 · Clin Nucl Med · 2024-01-24

本研究回顾性评估335例弥漫性大B细胞淋巴瘤患者,均行基线18F-FDG PET/CT,其中252例行中期PET/CT、213例行治疗结束PET/CT,由2名核医学医师分别用Lugano、RECIL和PERCIST判读。三种标准均可预测无进展生存期和总生存期;中期PET/CT中Lugano预测PFS和OS的一致性指数高于RECIL(均P=0.043)或PERCIST(P=0.008和P=0.034),治疗结束PET/CT中Lugano预测PFS和OS的一致性指数与RECIL相似、与PERCIST无显著差异(P=0.597和P=0.231)。

要点

  • 三种疗效标准均可预测弥漫性大B细胞淋巴瘤的PFS和OS。
  • 中期PET/CT中Lugano预测PFS和OS优于RECIL和PERCIST。
  • 治疗结束PET/CT中PERCIST略优。

核心结论

  • 中期PET/CT使用Lugano标准预测PFS和OS比RECIL或PERCIST更准确,而治疗结束PET/CT中PERCIST标准略优。

研究设计与样本

  • 回顾性评估335例弥漫性大B细胞淋巴瘤患者,均行基线18F-FDG PET/CT,其中252例行中期PET/CT、213例行治疗结束PET/CT,由2名核医学医师用Lugano、RECIL和PERCIST判读。

主要发现

  • 三种疗效标准均可用于预测PFS和OS。
  • 中期PET/CT中Lugano预测PFS和OS的一致性指数高于RECIL(均P=0.043)或PERCIST(P=0.008和P=0.034)。
  • 治疗结束PET/CT中Lugano预测PFS和OS的一致性指数与RECIL相似,与PERCIST无显著差异(P=0.597和P=0.231)。

关键数值与推荐

  • 中期PET/CT中Lugano预测PFS和OS的一致性指数高于RECIL(均P=0.043)。
  • 中期PET/CT中Lugano预测PFS的一致性指数高于PERCIST(P=0.008)。
  • 中期PET/CT中Lugano预测OS的一致性指数高于PERCIST(P=0.034)。
  • 治疗结束PET/CT中Lugano预测PFS的一致性指数与PERCIST无显著差异(P=0.597)。
  • 治疗结束PET/CT中Lugano预测OS的一致性指数与PERCIST无显著差异(P=0.231)。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: This study aimed to compare the criteria of the Lugano, RECIL, and PERCIST for prognosis in patients with diffuse large B-cell lymphoma. PATIENTS AND METHODS: We retrospectively evaluated 335 patients with diffuse large B-cell lymphoma. All patients underwent baseline 18 F-FDG PET/CT. Among them, 252 and 213 patients underwent interim PET/CT (I-PET/CT) and end-of-treatment PET/CT (EoT-PET/CT), respectively. Scans were interpreted by 2 nuclear medicine physicians using Lugano, RECIL, and PERCIST. RECIL and PERCIST were compared with Lugano for predicting progression-free survival (PFS) and overall survival (OS). RESULTS: All 3 response criteria could be used to predict PFS and OS. In I-PET/CT, the concordance index of Lugano in predicting PFS and OS was higher than that of RECIL (both P = 0.043) or PERCIST ( P = 0.008 and P = 0.034, respectively). In EoT-PET/CT, the concordance index of Lugano for predicting PFS and OS was similar to RECIL and not significantly different from PERCIST ( P = 0.597 and P = 0.231, respectively). CONCLUSIONS: For I-PET/CT, using the Lugano criteria is more accurate than RECIL or PERCIST in predicting PFS and OS. However, for EoT-PET/CT, the PERCIST criteria are minimally better.

来源:Clin Nucl Med,查看原文。版权归原作者所有。

引用

  1. Tang P, Cui F, Jiang C, et al. Comparison of Lugano Criteria Versus RECIL and PERCIST as Prognostic Factors in Diffuse Large B-Cell Lymphoma. Clin Nucl Med. 2024. PMID: 38271234. doi:10.1097/RLU.0000000000005068

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。